Cat. No.: BMMO-2603-CXX-005
Description: This organogel is produced from basement membrane components isolated from mouse tumor tissue and contains laminin, collagen IV, and heparan sulfate proteoglycans as its primary structural elements. In addition, Matrigel incorporates a variety of growth factors, including EGF, PDGF, NGF, FGF-2, and TGF-β.
Price: Inquiry
Datasheet: Datasheet
| Size | 1.5 mL×8 |
| Applications | Elevated protein concentration correlates with increased matrix stiffness and scaffold integrity. It is well-suited for in vivo cell delivery, enhancing cell implantation outcomes and facilitating solid tumor development. |
| Product Characteristics | This product is liquid at 4°C but forms a gel when heated to 37°C. Once solidified, the Matrigel can liquefy again if returned to 4°C overnight. |
| Storage | It is recommended that the product be aliquoted into single-use portions immediately after the first thaw and stored at -80°C for up to 2 years. |
| Shipping Information | Shipping with dry ice. |
| Notes | As this matrix gel solidifies when the temperature exceeds 10°C, it is essential to keep it on ice at all times during handling. To release organoids during passaging without exposing them to enzymes, gently pipette the gel using a pre-chilled basal culture medium (4°C). |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.
